Rural telemedicine use before and during the COVID-19 pandemic: a repeated cross-sectional study
Chu C, Cram P, Pang A, Stamenova V, Tadrous M, Bhatia RS. J Med Internet Res. 2021; 23(4):e26960. Epub 2021 Mar 24.
Publications
Dental opioid prescription characteristics and the risk of new, persistent use
Campbell TJ, Martins D, Tadrous M, Juurlink DN, Paterson JM, Mamdani MM, Mock D, Gomes T. Am J Prev Med. 2021; 60(6):831-9. Epub 2021 Mar 17.
Virtual care use before and during the COVID-19 pandemic: a repeated cross-sectional study
Bhatia RS, Chu C, Pang A, Tadrous M, Stamenova V, Cram P. CMAJ Open. 2021; 9(1):E107-14. Epub 2021 Feb 17.
Prescribing trends in direct-acting antivirals for the treatment of hepatitis C in Ontario, Canada
Tadrous M, Mason K, Dodd Z, Guyton M, Powis J, McCormarck D, Gomes T. Can Liver J. 2021; 4(1):51-8. Epub 2020; Dec 18.
Initial opioid prescription patterns and the risk of ongoing use and adverse outcomes
Gomes T, Campbell T, Tadrous M, Mamdani MM, Paterson MJ, Juurlink DN. Pharmacoepidemiol Drug Saf. 2021; 30(3):379-89. Epub 2020 Dec 10.
Impact of policy changes on the provision of naloxone by pharmacies in Ontario Canada: a population-based time series analysis
Antoniou T, Martins D, Campbell T, Tadrous M, Munro C, Leece P, Mamdani M, Juurlink DN, Gomes T. Addiction. 2021; 116(6):1514-20. Epub 2020 Nov 18.
Geographic variation in the provision of naloxone by pharmacies in Ontario, Canada: a population-based small area variation analysis
Antoniou T, McCormack D, Campbell T, Sutradhar R, Tadrous M, Lum-Wilson N, Leece P, Munro C, Gomes T. Drug Alcohol Depend. 2020; 216:108238. Epub 2020 Aug 19.
Spending on hepatitis C antivirals in the United States and Canada, 2014 to 2018
Shakeri A, Srimurugathasan N, Suda KJ, Gomes T, Tadrous M. Value Health. 2020; 23(9):1137-41. Epub 2020 Jul 28.
Effect of academic detailing on promoting appropriate prescribing of antipsychotic medication in nursing homes: a cluster randomized clinical trial
Tadrous M, Fung K, Desveaux L, Gomes T, Taljaard M, Grimshaw JM, Bell CM, Ivers NM. JAMA Netw Open. 2020; 3(5):e205724. Epub 2020 May 26.
Identifying drugs with disease‐modifying potential in Parkinson’s disease using artificial intelligence and pharmacoepidemiology
Maclagan LC, Visanji NP, Cheng Y, Tadrous M, Lacoste AMB, Kalia LV, Bronskill SE, Marras C. Pharmacoepidemiol Drug Saf. 2020; 29(8):864-72. Epub 2020 May 14.